RCC2 contributes to tumor invasion and chemoresistance to cisplatin in hepatocellular carcinoma (vol 33, pg 709, 2020)

被引：1
|
作者：
Chen, Qingmin [1 ]
Jiang, Peiqiang [1 ]
Jia, Baoxing [1 ]
Liu, Yahui [1 ]
Zhang, Ze [1 ,2 ]
机构：
[1] First Hosp Jilin Univ, Dept Gen Surg, Changchun 130021, Jilin, Peoples R China
[2] Jilin Univ, Dept Hepatobiliary Pancreat Surg, China Japan Union Hosp, 126 Xiantai St, Changchun 130000, Jilin, Peoples R China
来源：
HUMAN CELL | 2021年 / 34卷 / 02期
关键词：
D O I：
10.1007/s13577-020-00480-1
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：706 / 710
页数：5
相关论文
共 50 条
  • [1] RCC2 contributes to tumor invasion and chemoresistance to cisplatin in hepatocellular carcinoma
    Chen, Qingmin
    Jiang, Peiqiang
    Jia, Baoxing
    Liu, Yahui
    Zhang, Ze
    HUMAN CELL, 2020, 33 (03) : 709 - 720
  • [2] Retraction Note: RCC2 contributes to tumor invasion and chemoresistance to cisplatin in hepatocellular carcinoma
    Qingmin Chen
    Peiqiang Jiang
    Baoxing Jia
    Yahui Liu
    Ze Zhang
    Human Cell, 38 (3)
  • [3] Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin (vol 39, pg 135, 2020)
    Cai, Shijiao
    Bai, Yunpeng
    Wang, Huan
    Zhao, Zihan
    Ding, Xiujuan
    Zhang, Heng
    Zhang, Xiaoyun
    Liu, Yantao
    Jia, Yan
    Li, Yinan
    Chen, Shuang
    Zhou, Honggang
    Liu, Huijuan
    Yang, Cheng
    Sun, Tao
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [4] MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin (Expression of Concern of Vol 12, Pg 759, 2019)
    Yin, Z.
    Ren, W.
    ONCOTARGETS AND THERAPY, 2022, 15 : 841 - 841
  • [5] RETRACTION: MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin (Retraction of Vol 12, Pg 759, 2019)
    Yin, Z.
    Ren, W.
    ONCOTARGETS AND THERAPY, 2023, 16 : 471 - 471
  • [6] A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance (vol 694, pg 419, 2019)
    Wang, Wei
    Hu, Bo
    Qin, Jiang-Jiang
    Cheng, Jianwen
    Li, Xin
    Rajaei, Mehrdad
    Fan, Jia
    Yang, Xin-Rong
    Zhang, Ruiwen
    GENES & DISEASES, 2020, 7 (01) : 160 - 161
  • [7] Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer (vol 8, 840, 2020)
    Wang, Lin
    Ji, Xiang-Bo
    Wang, Li-Hong
    Qiu, Jian-Ge
    Zhou, Feng-Mei
    Liu, Wen-Jing
    Wan, Di-Di
    Lin, Marie Chai-Mi
    Liu, Ling-Zhi
    Zhang, Jian-Ying
    Jiang, Bing-Hua
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [8] MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7 (vol 34, pg 2576, 2015)
    Yang, Wei
    Dou, Changwei
    Wang, Yufeng
    Jia, Yuli
    Li, Chao
    Zheng, Xin
    Tu, Kangsheng
    ONCOLOGY REPORTS, 2023, 50 (02)
  • [9] Tumor-Specific Transcripts Are Frequently Expressed in Hepatocellular Carcinoma With Clinical Implication and Potential Function (vol 71, pg 259, 2020)
    Zheng, Qiupeng
    Zhao, Jingjing
    Yu, Hui
    Zong, Huajie
    He, Xigan
    Zhao, Yiming
    Li, Yan
    Wang, Yu
    Bao, Yichao
    Li, Yuchen
    Chen, Bing
    Guo, Weijie
    Wang, Yilin
    Chen, Zhiao
    Zhao, Yingjun
    Wang, Lu
    He, Xianghuo
    Huang, Shenglin
    HEPATOLOGY, 2021, 74 (05) : 2929 - 2929
  • [10] Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma (Expression of Concern of Vol 40, art no BSR20194026, 2020)
    不详
    BIOSCIENCE REPORTS, 2022, 42 (06)
12345